Covalon Technologies (CVE:COV) Stock Price Down 15% – Should You Sell?

Covalon Technologies Ltd. (CVE:COV)’s share price was down 15% during mid-day trading on Tuesday . The company traded as low as C$2.80 and last traded at C$3.05. Approximately 188,058 shares traded hands during mid-day trading, an increase of 115% from the average daily volume of 87,410 shares. The stock had previously closed at C$3.59.

Covalon Technologies Stock Performance

The company has a market cap of C$86.04 million, a P/E ratio of -78.50 and a beta of 0.64. The company’s fifty day moving average is C$3.54 and its 200 day moving average is C$3.03. The company has a current ratio of 5.24, a quick ratio of 6.45 and a debt-to-equity ratio of 4.98.

About Covalon Technologies

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.